GCG and diabetes mellitus: Administration of glucagon-like peptide-1 for a duration of 5 weeks resulted in improvement in LVEF and functional status in patients with chronic heart failure and comorbid diabetes, which suggests that insulin resistance is implicated in the pathogenesis of cardiomyopathy in diabetes mellitus (275).